PRIMARY SCLEROSING CHOLANGITIS - REFINEMENT AND VALIDATION OF SURVIVAL MODELS

被引:219
作者
DICKSON, ER
MURTAUGH, PA
WIESNER, RH
GRAMBSCH, PM
FLEMING, TR
LUDWIG, J
LARUSSO, NF
MALINCHOC, M
CHAPMAN, RW
KAPLAN, MM
MADDREY, WC
WILLIAMS, R
FARRANT, M
LANGWORTHY, A
机构
[1] MAYO CLIN & MAYO FDN,MED PATHOL SECT,ROCHESTER,MN 55905
[2] JOHN RADCLIFFE HOSP,OXFORD OX3 9DU,ENGLAND
[3] NEW ENGLAND MED CTR,BOSTON,MA
[4] UNIV TEXAS,SW MED CTR,DALLAS,TX 75230
[5] UNIV LONDON KINGS COLL HOSP,INST LIVER STUDIES,LONDON SE5 8RX,ENGLAND
[6] UNIV WASHINGTON,DEPT BIOSTAT,SEATTLE,WA 98195
关键词
D O I
10.1016/0016-5085(92)91449-E
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The natural history of primary sclerosing cholangitis was studied in 426 patients from five medical centers. The median follow-up time was 3.0 years (range, 0.01-16.6 years); 100 patients had died by the time of last follow-up. Survival analysis (Cox proportional-hazards regression) was used to identify the variables most useful in predicting survival of patients with primary sclerosing cholangitis. Serum bilirubin concentration, histological stage on liver biopsy, age, and the presence of splenomegaly were independent predictors of a high risk of dying. A mathematical model to predict survival of patients with primary sclerosing cholangitis (based on referral values of those predictors) was statistically validated using two methods. Confidence intervals for predicting patient-specific survival probabilities are also presented. This model to predict survival could be used to stratify participants in therapeutic trials, counsel patients and their families, decide on candidacy for and timing of liver transplantation, and provide mathematical controls for evaluating the efficacy of therapies for primary sclerosing cholangitis, including transplantation. © 1992.
引用
收藏
页码:1893 / 1901
页数:9
相关论文
共 23 条
  • [1] CHAPMAN RW, 1981, DIGEST DIS SCI, V26, P78
  • [2] PRIMARY SCLEROSING CHOLANGITIS - A REVIEW OF ITS CLINICAL-FEATURES, CHOLANGIOGRAPHY, AND HEPATIC HISTOLOGY
    CHAPMAN, RWG
    ARBORGH, BAM
    RHODES, JM
    SUMMERFIELD, JA
    DICK, R
    SCHEUER, PJ
    SHERLOCK, S
    [J]. GUT, 1980, 21 (10) : 870 - 877
  • [3] MULTIVARIATE SURVIVAL ANALYSIS USING COX REGRESSION-MODEL
    CHRISTENSEN, E
    [J]. HEPATOLOGY, 1987, 7 (06) : 1346 - 1358
  • [4] COX DR, 1972, J R STAT SOC B, V34, P187
  • [5] PRIMARY SCLEROSING CHOLANGITIS
    DICKSON, ER
    LARUSSO, NF
    WIESNER, RH
    [J]. HEPATOLOGY, 1984, 4 (01) : S33 - S35
  • [6] PROGNOSIS IN PRIMARY BILIARY-CIRRHOSIS - MODEL FOR DECISION-MAKING
    DICKSON, ER
    GRAMBSCH, PM
    FLEMING, TR
    FISHER, LD
    LANGWORTHY, A
    [J]. HEPATOLOGY, 1989, 10 (01) : 1 - 7
  • [7] DOWNTON F, 1972, J R STAT SOC B, V34, P202
  • [8] Efron B, 1982, JACKKNIFE BOOTSTRAP
  • [9] NATURAL-HISTORY AND PROGNOSTIC VARIABLES IN PRIMARY SCLEROSING CHOLANGITIS
    FARRANT, JM
    HAYLLAR, KM
    WILKINSON, ML
    KARANI, J
    PORTMANN, BC
    WESTABY, D
    WILLIAMS, R
    [J]. GASTROENTEROLOGY, 1991, 100 (06) : 1710 - 1717
  • [10] EXTRAMURAL CROSS-VALIDATION OF THE MAYO PRIMARY BILIARY-CIRRHOSIS SURVIVAL MODEL ESTABLISHES ITS GENERALIZABILITY
    GRAMBSCH, PM
    DICKSON, ER
    KAPLAN, M
    LESAGE, G
    FLEMING, TR
    LANGWORTHY, AL
    [J]. HEPATOLOGY, 1989, 10 (05) : 846 - 850